Durda P J, Gottlieb P D
J Immunol. 1978 Sep;121(3):983-9.
Anti-Lyt-2.1 and anti-Lyt-3.1 sera were employed for sequential precipitation of NP-40 extracts of 125I-labeled C57BL/6-Lyt-2a, Lyt-3a thymocytes (Lyt-2.1, Lyt-3.1) to determine whether these alloantigenic determinants are present on the same or different molecular species. Treatment of extracts with anti-Lyt-3.1 serum and SaCI completely precipitated both Lyt-3.1 and Lyt-2.1-specific components, whereas treatment with anti-Lyt-2.1 serum reduced by approximately 37% the quantity of labeled species subsequently precipitable by anti-Lyt-3.1 serum. When 125I-labeled thymocytes were subjected to mild trypsinization before NP-40 extraction, the quantity of radioactive components precipitated by anti-Lyt-2.1 serum was essentially unchanged, but that of anti-Lyt-3.1-precipitable components was greatly reduced. Moreover, sequential precipitation of extracts of trypsinized thymocytes with anti-Lyt-2.1 and anti-Lyt-3.1 sera demonstrated that these molecular species were precipitated independently. Thus 1) Lyt-2.1 and Lyt-3.1 antigenic determinants appear to reside on different molecular species; 2) some Lyt-2.1- and Lyt-3.1-positive molecules appear to be complexed with each other in the NP-40 extract; and 3) this association of Lyt-2.1- and Lyt-3.1-positive species was dependent upon components that were labile to trypsinization of intact thymocytes.
使用抗Lyt-2.1和抗Lyt-3.1血清对125I标记的C57BL/6-Lyt-2a、Lyt-3a胸腺细胞(Lyt-2.1、Lyt-3.1)的NP-40提取物进行连续沉淀,以确定这些同种异型抗原决定簇是存在于同一分子还是不同分子上。用抗Lyt-3.1血清和盐处理提取物可完全沉淀Lyt-3.1和Lyt-2.1特异性成分,而用抗Lyt-2.1血清处理后,随后用抗Lyt-3.1血清可沉淀的标记物数量减少了约37%。当125I标记的胸腺细胞在NP-40提取前进行轻度胰蛋白酶处理时,抗Lyt-2.1血清沉淀的放射性成分数量基本不变,但抗Lyt-3.1可沉淀成分的数量大大减少。此外,用抗Lyt-2.1和抗Lyt-3.1血清对胰蛋白酶处理的胸腺细胞提取物进行连续沉淀表明,这些分子是独立沉淀的。因此,1)Lyt-2.1和Lyt-3.1抗原决定簇似乎存在于不同的分子上;2)在NP-40提取物中,一些Lyt-2.1和Lyt-3.1阳性分子似乎相互结合;3)Lyt-2.1和Lyt-3.1阳性分子的这种结合依赖于完整胸腺细胞经胰蛋白酶处理后不稳定的成分。